missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Methotrexate, Fisher BioReagents
Description
- Inhibitor of DNA and RNA synthesis
- Inhibits the enzyme responsible for synthesizing the folic acid derivative that is necessary for purine and pyrimidine synthesis
- The lack of purines and pyrimidines impacts the synthesis of DNA, RNA, and proteins
- Referenced for use in antitumor studies and other studies of biological pathways
- Intended for research use only
Specifications
Spezifikation
| Decomposition Information | >195°C |
| Melting Point | 195°C |
| Color | Yellow |
| Ignition Residue | 0.1% max. |
| Assay Percent Range | 98.0 to 102.0 % |
| Packaging | Amber Glass |
| Quantity | 10 mg |
| Merck Index | 15, 6057 |
| Specific Rotation | +19.0 to +24.0° (+ or -) |
| Formula Weight | 454.44 |
| Mehr anzeigen |
Sicherheit und Handhabung
Produktidentifikator
- Methotrexate
- Danger
- Acute toxicity Category 3
- Serious eye damage/eye irritation Category 2
- Germ cell mutagenicity Category 1B
- Reproductive toxicity Category 1B
- Skin corrosion/irritation Category 2
- Specific target organ toxicity Category 3
- H340-May cause genetic defects.
- H360FD-May damage fertility. May damage the unborn child.
- H315-Causes skin irritation.
- H319-Causes serious eye irritation.
- H335-May cause respiratory irritation.
- H301-Toxic if swallowed.
- P280-Wear protective gloves/protective clothing/eye protection/face protection.
- P305+P351+P338-IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
- P308+P313-IF exposed or concerned: Get medical advice/attention.
Name des Produkts
Indem Sie auf Absenden klicken, erklären Sie sich damit einverstanden, dass Fisher Scientific sich mit Ihnen in Verbindung setzen kann, um Ihr Feedback in diesem Formular zu bearbeiten. Wir werden Ihre Informationen nicht für andere Zwecke weitergeben. Alle bereitgestellten Kontaktinformationen werden in Übereinstimmung mit unserer Datenschutzrichtlinie aufbewahrt. Datenschutzrichtlinie.
Haben Sie Verbesserungsvorschläge?